A pilot study of adherence to lenalidomide among older patients with multiple myeloma

被引：1
|
作者：
Silberstein, Alice E. [1 ]
Fiala, Mark A. [1 ,2 ]
Loh, Kah Poh [3 ]
Cordner, Theresa [1 ]
Mian, Hira [4 ]
Wildes, Tanya M. [5 ,6 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] St Louis Univ, Coll Publ Hlth & Social Justice, St Louis, MO USA
[3] Univ Rochester, James P Wilmot Canc Inst, Dept Med, Div Hematol Oncol,Med Ctr, Rochester, NY USA
[4] McMaster Univ, Hamilton, ON, Canada
[5] Univ Nebraska Med Ctr, Div Hematol Oncol, Nebraska Med, Omaha, NE USA
[6] 983332 Nebraska Med Ctr, Omaha, NE 68198 USA
来源：
JOURNAL OF GERIATRIC ONCOLOGY | 2023年 / 14卷 / 07期
基金：
美国国家卫生研究院;
关键词：
MEDICATION ADHERENCE; COSTS;
D O I：
10.1016/j.jgo.2023.101560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Lenalidomide in multiple myeloma
    Sirohi, Bhawna
    Powles, Ray
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (11) : 1559 - 1570
  • [22] Lenalidomide in multiple myeloma
    Thomas, Sheeba K.
    Richards, Tiffany A.
    Weber, Donna M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 717 - 735
  • [23] Lenalidomide in multiple myeloma
    Kim, Young
    Schmidt-Wolf, Ingo G. H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (05) : 491 - 497
  • [24] Clinical and Correlative Pilot Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRd - R) In High Risk Smoldering Multiple Myeloma Patients
    Landgren, Ola
    Mailankody, Sham
    Kwok, Mary
    Manasanch, Elisabet E.
    Bhutani, Manisha
    Tageja, Nishant
    Kazandjian, Dickran
    Zingone, Adriana
    Costello, Rene
    Burton, Debra
    Zhang, Yong
    Wu, Peter
    Carter, George
    Mulquin, Marcia
    Zuchlinski, Diamond
    Maric, Irina
    Calvo, Katherine R.
    Braylan, Raul C.
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    Arthur, Diane C.
    Lindenberg, Liza
    Kurdziel, Karen
    Choyke, Peter
    Steinberg, Seth M.
    Roschewski, Mark
    Korde, Neha
    BLOOD, 2013, 122 (21)
  • [25] Efficacy of lenalidomide plus dexamethasone in patients older than 75 years with relapsed multiple myeloma
    Touzeau, Cyrille
    Blin, Nicolas
    Clavert, Aline
    Roland, Virginie
    Loirat, Marion
    Tessoulin, Benoit
    Le Gouill, Steven
    Planche, Lucie
    Pennetier, Martine
    Mahe, Beatrice
    Mohty, Mohamad
    Malard, Florent
    Peterlin, Pierre
    Dubruille, Viviane
    Moreau, Philippe
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1318 - 1320
  • [26] Medication Beliefs and Antihypertensiye Adherence Among Older Adults: A Pilot Study
    Ruppar, Todd M.
    Dobbels, Fabienne
    De Geest, Sabina
    GERIATRIC NURSING, 2012, 33 (02) : 89 - 95
  • [27] GFR estimation in lenalidomide treatment of multiple myeloma patients: a prospective cohort study
    Schmidts, Andrea
    Gruenewald, Julian
    Kleber, Martina
    Terpos, Evangelos
    Ihorst, Gabriele
    Reinhardt, Heike
    Walz, Gerd
    Waesch, Ralph
    Engelhardt, Monika
    Zschiedrich, Stefan
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (02) : 199 - 206
  • [28] GFR estimation in lenalidomide treatment of multiple myeloma patients: a prospective cohort study
    Andrea Schmidts
    Julian Grünewald
    Martina Kleber
    Evangelos Terpos
    Gabriele Ihorst
    Heike Reinhardt
    Gerd Walz
    Ralph Wäsch
    Monika Engelhardt
    Stefan Zschiedrich
    Clinical and Experimental Nephrology, 2019, 23 : 199 - 206
  • [29] Survival of Patients with Multiple Myeloma That Is Refractory to Both Bortezomib and Lenalidomide: A Retrospective Study
    Miyazaki, Kanji
    Suzuki, Kenshi
    BLOOD, 2018, 132
  • [30] THOMBOPROPHYLAXIS IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE OR THALIDOMIDE
    Palmaro, A.
    Despas, F.
    Lapeyre-Mestre, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E65 - E65
12345